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Abstract
Background: Pharmacist involvement in the prevention of medication errors is well documented. One such
method, the process by which hospital pharmacists undertake these clinical interventions needs to be described
and documented. The perceived barriers to pharmacists succeeding in getting their recommendations accepted
could inform future safety strategy development. This study was therefore to trace the typical process involved and
explore the perceived barriers to pharmacists’ medication safety efforts.
Methods: This study involved a retrospective evaluation of routine clinical interventions collected at a tertiary
hospital in Ghana over 23 months. A sample of pharmacists who had submitted these reports were then interviewed.
Results: The interventions made related to drug therapy changes (76.0 %), monitoring (13.0 %), communication (5.4 %),
counselling (5.0 %) and adverse drug events (0.6 %). More than 90 % of interventions were accepted. The results also
showed that undertaking clinical interventions by pharmacists followed a sequential order with two interlinked
subprocesses: Problem Identification and Problem Handling. In identifying the problem, as much information needed to
be gathered, clinical issues identified and then the problems prioritised. During the problem handling stage, detailed
assessment was made which led to the development of a pharmaceutical plan. The plan was then implemented and
monitored to ensure appropriateness of desired outcomes.
The main barrier mentioned by pharmacist related to the discrepant attitudes of doctors/nurses. The other
barriers encountered during these tasks related to workload, and inadequate clinical knowledge. The attitudes
were characterised by conflicts and egos resulting from differences in status/authority, responsibilities, and training.
Conclusions: Though the majority of recommendations from pharmacists were accepted, the main barrier to hospital
pharmacist engagement in medication error prevention activities related to discrepant attitudes of doctors and nurses.
Proper initiation and maintenance of collaborative working relationship in hospitals is desired between the healthcare
team members to benefit from the medication safety services of hospital pharmacists.
Background
The clinical values of pharmacists’ intervention and its
positive contribution to the quality of pharmacotherapy
have been confirmed in literature [1–3]. For example, in
an acute care geriatric unit, 76 interventions were made
in 3-month period in pharmacotherapy areas that in-
cluded drug selection, dosing, changes in therapy, and
medication reconciliation [4]. The clinical role of phar-
macists involves preventing, identifying, and resolving
medication errors. The involvement of pharmacists to
reduce the risk and harm of medication errors is thus
complementary to many recent automated or mechan-
ical improvements relating to prescribing, dispensing
and administering medications. Pharmacist interventions
have been shown to positively affect clinical health out-
comes such as morbidity and adverse drug events [2, 5].
Though the majority of medication related errors do not
reach the patient due to pharmacists, nurses and other
healthcare professionals, their potential to cause morbid-
ity and mortality is significant [6]. Undoubtedly, medica-
tion errors that have been prevented need to be studied.
When interventions are made, it means an accident se-
quence was initiated and then by the actions of the
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individual, team or organisation it was prevented from
having negative consequences. Documentation of the in-
terventions is important for justifying pharmacists’ ser-
vices to the patient, healthcare managers and providers,
patient care takers, and to strengthen the profession [7].
Usually, there are some barriers to undertaking this very
important clinical function of pharmacist. Clinical inter-
ventions also go through well-thought processes that
would inform practitioners and assist in planning spe-
cific roles for pharmacists along the process nodes.
The objectives of the study were:
 Evaluate clinical intervention reports submitted by
hospital pharmacists
 Describe the processes involved in performing
clinical interventions by hospital pharmacists.
 Explore the perceived barriers encountered by




The study took place at Korle Bu Teaching hospital which
is a 2000 bed tertiary teaching hospital located in the cap-
ital city of Ghana. At the time of the study, the hospital
had about 80 pharmacists. The main pharmacy services
provided in the hospital were dispensing, clinical services,
drug information, research and small scale manufacturing.
There were about 30 pharmacists who actively undertook
clinical duties across the various wards of the hospital to-
gether with other health care professionals.
Study design
The study involved a retrospective evaluation of clinical
intervention reports of hospital pharmacists who were
engaged in direct patient care. This was almost immedi-
ately followed by key informant interviews with sampled
pharmacists whose clinical intervention reports had
been evaluated. Interview techniques are useful in gain-
ing rich insight into a subject matter. Researchers used
interviews to explore the possible causes of different
types of medication errors [8–11]. The interview process
probes and provides detailed information as well as other
useful information that the researcher had not considered
prior to the start of a study. Authors have pointed to the
utility of interview techniques in gaining rich information
regarding patient safety incidents [12, 13]. Interviews were
then subjected to thematic content analysis. Braun and
Clarke [14] developed the five stages of content analysis
which has been described in Fig. 1.
Data collection
In determining the eligible participants for the key in-
formant interview, the outcome of the review of
intervention reports was used. Evaluation of the inter-
vention reports revealed that 24 pharmacists reported
clinical interventions during the period January 2011 to
December 2013. As at the time of the interview, 5 phar-
macists were not available to be interviewed. Addition-
ally, 2 pharmacists were no longer actively performing
clinical duties. Seventeen pharmacists were finally de-
clared eligible to participate in the study and they were
all invited with a letter. In addition to the letter, informa-
tion sheets and consent forms were added. The inter-
viewees had varying degree of experience, in terms of
years of practice and professional grade. Interviewees
who had spent less than 5 years in practice submitted
slightly higher intervention reports. Two major categor-
ies were sought from interviewees’ response to questions
which focused on how participants thought through the
process they used and the challenges experienced in
undertaking interventions.
With the aid of semi-structured guide, the interviews
were conducted in the pharmacists’ offices between 11th
March and 8th April 2014. The interview lasted between
30 and 35 min. Interviews were recorded with an audio
recorder with the permission of each participant. Inter-
views were then transcribed verbatim. The transcripts of
the interviews were coded to maintain confidentiality of
interviewees and then subjected to content analysis to
draw out common themes.
Fig. 1 Stages of Thematic Content analysis of interviews recommended
by Braun and Clarke adopted from ‘Identifying the Latent Failures
Underpinning Medication Administration Errors: An Exploratory
Study’ by Lawton et al. [36]
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Ethical approval was obtained from the Ethical and
Protocol Review Committee of the University of Ghana
Medical School.
Results
Twenty four pharmacists made 1019 clinical interven-
tions in 448 handwritten reports. The interventions re-
lated to drug therapy changes (76.0 %), monitoring
(13.0 %), communication (5.4 %), counselling (5.0 %) and
adverse drug events (0.6 %). More than 90 % of interven-
tions and recommendations by pharmacists were accepted
and implemented whilst over 70 % of the interventions in-
volved drug regimen change.
A total of 17 pharmacists were invited to participate in
the interviews. Out of this, 12 pharmacists (70.6 %)
agreed to be interviewed and completed consent forms.
The characteristics of the interviewees are summarised
in Table 1.
Process sequence
Respondents described the process used in performing
clinical interventions. Undertaking clinical interventions
followed a sequential order which is made up of two
linked subprocesses. The two subprocesses were Prob-
lem Identification and Problem Handling. In identifying
the problem, as much information needed to be gath-
ered, clinical issues identified and then the problems
prioritised. During the problem handling stage, detailed
assessment was made which led to the development of a
pharmaceutical plan. The plan was then implemented and
monitored to ensure appropriateness of desired outcomes.
Figure 2 shows a schematic representation of the vari-
ous steps taken by participants in their clinical interven-
tion process. The following are some excerpts:
Gathering of information
Interviewees mentioned that they gather relevant informa-
tion by reviewing patients’ medical notes, talking to pa-
tients, their relatives, nurses or physicians. Two participants
described how they gather information on patients:
“In obtaining relevant information, we review patients’
medical and biomedical records like the LFT’s. An
example is a patient may be on a correct dose or
frequency of a drug but it maybe contraindicated
because the LFT’s maybe deranged so there comes the
need for varying dose frequencies for that particular
patient.” (Participant004)
“Participating in ward rounds with other healthcare
professionals also provide pharmacists the opportunity
to discuss the patients in details and thereby obtain
first-hand patient information.” (Participant 001)
Identification of issues
Respondents then identified pharmaceutical issues that
required interventions. The issues mentioned were
medication errors. The issues formed the basis for the
interventions. They included prescribing errors, dis-
pensing errors, medication administration errors, mon-
itoring requirements, counselling requirement, and
adverse drug reaction reporting. A quote illustrates this
point:
“You look at the diagnosis, look at the vital signs,
relate it to the medications and find out if there is any
problems. You watch out for drug-drug interactions,
adverse effects related to the medication. We have the
opportunity to look at lab reports and other investiga-
tions. We look at other parameters like urine output,
blood sugar, patient weight and link it to patients’
medication too.” (Participant 011)
Development of pharmaceutical plan
After the problems had been identified, a plan was de-
signed. The plan involved the actions to be taken to re-
solve the problem. This was illustrated by respondents.
“We start by assessing the identified problems, using the
background knowledge in drug therapy. After assessing
the problems we plan on how the changes can be made.
This involves consulting the medical practitioner in
charge of the said patient.” (Participant 001)
Communicating/Implementation of plan
After a plan has been developed, it is either communicated
or implemented. Pharmacist compared the plan with local,
regional or international protocols. These plans were pa-
tient centred as summarised by a respondent:











Senior Pharmacist 3 98
Principal Pharmacist 3 71
Specialist Pharmacist 2 81
Median number of intervention reports
per pharmacist (n = 24) (min-max)
22 (16–28)
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“Usually once you identify a problem, you need to
draw the attention of the other healthcare
professionals about the problem identified and
obviously help find a solution to it. Sometimes you will
get queries demanding a defense to your point, most of
which is done verbally.” (Participant 005)
Monitoring or feedback
Respondents mentioned that this stage of the process was
to compare results with desired outcomes and ensured
minimum side effects. Two excerpts are provided below:
“When all is said and done, you cannot go to sleep.
You have to plan to monitor the interventions made.
You will need feedback of a sort. Say, clinical outcome
etc.” (Participant 002)
“After that, we evaluate the changes.” (Participant 005)
Barriers to performing clinical interventions
All respondents stated that they experienced one chal-
lenge or another. Three secondary categories were iden-
tified as potential barriers to performing interventions.
They included workload, lack of clinical knowledge and
attitudes of doctors and nurses.
a) Workload
All the interviewees mentioned that workload was a
challenge they encountered daily. They commented that
they had to perform other roles like dispensing, stock
management etc. in addition to clinical roles.
“But sometimes the workload becomes too much to
bear that you even want to run away even though I
think its fulfilling especially when you see a patient
get better because of an intervention you made.”
(Participant 003)
“Because of time factor, it is very difficult for me to go
on ward rounds to identify patient care issues and
then make the necessary interventions. The same
person is managing the pharmacy, attending meetings
and so on.” (Participant 004)
b) Lack of adequate clinical knowledge,
Fig. 2 Schematic representation of clinical interventions process
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Adequate clinical knowledge is essential to undertake ef-
fective clinical roles. Ten out of the 12 participants agreed
that another major barrier was lack of clinical knowledge.
Participants supported the need for postgraduate degree
qualification for pharmacists to undertake this clinical role
effectively. Two participants illustrate this:
“Sometimes you feel inadequate, in terms of clinical
knowledge and extra training will be helpful. The first
degree is not adequate because it makes it difficult for
you to make contributions into challenging issues.”
(Participant 002)
“It’s sometimes intimidating because probably it’s a
consultant you are going to see and you are scared you
don’t have your facts right. And the doctors come to
the wards in bunches and we go single handedly.”
(Participant 010)
Participants also mentioned the lack of specialist train-
ing. Participants believe that specialist training will con-
tribute to enhancing clinical knowledge.
“What I am doing is general clinical pharmacy and I
feel inadequate sometimes because the cases are
specialist cases. If I were to specialize in a particular
area for example, cardiology, I think I would perform
better. And also it will add more width to my work
and people will appreciate my input more because I
will have more knowledge in a particular field.”
(Participant 011)
In contrast, a participant suggested that Pharm D
qualification would prepare pharmacy graduates to bet-
ter perform clinical roles immediately.
“I preferred Pharm D. training program which seeks to
make the pharmacist very capable of providing clinical
care at the point of completion of the course.”
(Participant 006)
c) Doctors’ and nurses’ attitudes
In the clinical settings, pharmacists work closely with
other healthcare professionals, especially doctors and
nurses. Participants mentioned that another major bar-
rier to their clinical role was the attitudes and percep-
tions of doctors and nurses. The statements below
summarise the point:
“There is this attitude of looking down on others by
doctors because of professional differences or
backgrounds, and they probably feel that one is
questioning their authority. Doctors, especially feel
superior because they are ultimately responsible for
the patient; they overuse that. It is purely an issue of
ego.” (Participant 012)
“A typical example was when a prescription of
vitamin C 3000 mg was written for a child of 2 years
by a house officer. I quickly wrote a note to indicate
the error in the prescription. He sent it back insisting
that it be given. He was particularly rude. I went to
him personally to inquire reasons he was insisting that
dose be given to a child of 2 years. It became a rather
tense and confrontational situation and I told him
that unless he changed the prescription I wasn’t going
to dispense the drug.” (Participant 005)
Some doctors and nurses are ignorant of the clinical
competence of pharmacists and these have the potential
of influencing their attitudes toward pharmacists. Below
are some quotes from what they said:
“There is this mentality that doctors are to take care of
patients and pharmacists are to look after drugs
without any consideration to how they were used at
all.” (Participant 011)
“There is always that doubt about the competence of
pharmacist by other professionals. Doctors are trained
that one has to prove his worth to be able to play a
role in patient management so it is only natural that
there will be some difficulty in accepting another
person who was not trained the same way as doctors.”
(Participant 010)
“There has to be a form of platform that seeks to
inform them of our abilities and readiness play
clinical roles and not just our traditional roles of
dispensing, manufacturing and the rest. We have
evidence. For example, when we got actively involved
in HIV care, our patients are well educated and we
are achieving 90 % adherence and most of our
patients are doing well.” (Participant 012)
“People even think that when it comes to hospital, its
doctor or nurse, finish!. Even though doctors and
nurses appreciate our work they seem to forget
themselves sometimes and forget our clinical roles.”
(Participant 003)
Lack of proper communication skills can also create
unfavourable working relationships with others and lead
to improper attitudes.
“Unfortunately the premise of interventions is more
like corrective and if you don’t have the right skills to
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make recommendations, they will become defensive.
No one wants to be told they have done mistakes,
especially doctors.” (Participant 011)
“Your approach, communication is very important, if
you don’t approach properly, then the other one thinks
you are discrediting his role or questioning his integrity
or knowledge, there must be rapport such that the
person would accept your input.” (Participant 002)
Lack of cooperation was also mentioned by partici-
pants as a barrier. Interviewees perceived that it some-
times appeared as if doctors and nurses were protecting
their turf. The following illustrates the assertion:
“It is purely the lack of collaboration and cooperation.
If the system does encourage people to meet and work
together in the interest of your patient, then it’s easier
for everybody to cooperate.” (Participant 007)
“There is the mentality that doctors and nurses are
supposed to be taking care of patients and we are
supposed to be taking care of products without
consideration to how they were used. The thought of
trying to be doctors by adding patient care to our
responsibilities will lead to them asking for the same
benefits they receive.” (Participant 012)
Discussion
The study evaluated the clinical intervention reports sub-
mitted by pharmacists working in a tertiary hospital and
explored the process involved and the potential barriers to
pharmacist clinical interventions. The pharmacists identi-
fied medication errors in the management of patients and
made interventions to prevent these errors from reaching
patients. Twenty four pharmacists made 1019 clinical in-
terventions in 448 handwritten reports. Majority of the in-
terventions related to drug therapy changes.
The most frequently reported medication errors
found in our study were medication regimen change
and originated from medication prescribing. Studies
have reported prescribing errors as a major contributor
to patient harm in hospitals [15–19]. This finding is
consistent with findings from other studies conducted
in clinical centres [16], tertiary [20], hospital inpatient
[15] and ambulatory care settings [21]. More than 90 %
of interventions and recommendations by pharmacists
were accepted and implemented.
Pharmacists are in an ideal position to provide on-
going medication therapy management services for their
patients. Error recovery is one of such important roles.
Pharmacist interventions have been shown to positively
affect clinical health outcomes such as morbidity and ad-
verse drug events [2, 5]. There are however barriers to
optimizing such a useful medication safety strategy. When
these barriers interfere with the pharmacist’s ability to per-
form interventions, serious errors may reach the patient.
Pharmacists clinical intervention in this study followed
a sequential process which was cyclical in nature (see
Fig. 2). The attributes of the process compares with the
process of providing pharmaceutical care which has been
described as a continuous quality improvement process
for the use of medications [22]. Hepler and Strand de-
scribed pharmaceutical care as the responsible provision
of medication therapy for the purpose of achieving def-
inite outcomes that improve or maintain a patient’s qual-
ity of life [23]. A fundamental element in optimising
patient outcomes is the routine addition of ongoing
monitoring to the medication use process through the
participation in patient care processes [24]. The process
as described begins by assessing the patient. This will in-
volve gathering information about the patient records.
The patient’s record will include medical history, past
and present drug therapies, social, family and drug al-
lergy history. The records are then reviewed to identify
the potential medical and pharmaceutical problems.
These identified problems are then prioritised based on
urgency and importance. In this prioritisation stage, the
desired outcomes for each problem are set out. This is done
to guide the formulation of individualised intervention.
Subsequently, a detailed assessment, making particular ref-
erence to co-morbidities, patient specific characteristics
etc., is made. The next stage will involve deciding which ac-
tions to take and how these actions are implemented. This
is done by referring to acceptable local or international
standards, protocols, guidelines and formulae. This is also
the stage where cost-benefit analyses are considered [25].
The plans are then implemented. Strategies are then put in
place to monitor and evaluate the intervention made.
The barriers to clinical interventions mentioned by in-
terviewees related to workload, inadequate clinical
knowledge and attitudes of doctors and nurses. Work-
load negatively affects pharmacists’ performance on vari-
ous activities undertaken at various settings [26–28].
Workload has been known as potential causes of medi-
cation errors [9]. In a study, pharmacist’s willingness or
ability to intervene in the case of prescription problems
decreased as the volume of prescriptions dispensed in-
creased [29]. Leape et al. [30] also found that workload
was a contributory factor to adverse drug events and
recommended reducing workload in hospitals.
Pharmacists mentioned that their inadequate clinical
knowledge affected their performance. Appropriate
knowledge about therapeutics will assist pharmacists in be-
ing seen as partners in the clinical management of patients.
Physician’s familiarity with and respect for a pharmacist’s
clinical abilities could support his or her willingness to
accept a pharmacist’s input. Pharmacists with the requisite
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clinical training and professional education are positioned
to prevent errors and help in patient management because
of their knowledge and skills in medication therapy and
their accessibility to patients [31]. Pharmacists are able to
blend a caring orientation with specialized therapeutic
knowledge, experience, and judgment for the purpose of
ensuring optimal patient outcomes [32].
The negative attitudes of doctors and nurses towards
pharmacist were identified as potential barriers. Discrep-
ant attitudes about healthcare teamwork characterised
by conflicts and egos resulted from differences in status/
authority, responsibilities, training, and nurse and doctor
cultures [33]. Hughes and McCann [34] found that doc-
tors did not appreciate pharmacists in healthcare. In this
study, though majority of the recommendations were ac-
cepted and implemented, pharmacists still mentioned
that they frequently experienced unfavourable attitudes
from doctors and nurses on the wards. The role of phar-
macists in the care of hospitalized patients has expanded
over time, with increased emphasis on collaborative care
and patient interaction. Pharmacy practice had to battle
with a strict historic model of physicians diagnosing and
prescribing while pharmacists compound and dispense.
In a study, increased awareness of all team members’
(pharmacists, nurses and doctors) potential roles played
a part in facilitating positive patient outcomes [35].
Fundamental to a good working relationship is when
egos are set aside and the focus is set on preventing and
solving medication errors with the intention of providing
the best possible care for the patient.
Study limitation
The length of time between when the pharmacist filed
the clinical intervention report and the interview might
have affected accuracy of recall by the pharmacists.
Conclusion
The retrospective study findings clearly showed that
clinical interventions formed a significant part of hos-
pital pharmacists’ activities. These clinical interventions
have been used to reduce the risk of medication errors
in previous studies.
The barriers to undertaking clinical interventions re-
lated to workload, inadequate clinical knowledge and
attitude of doctors and nurses. Although majority of
pharmacists’ recommendations were accepted, partici-
pants mentioned that a major barrier was the attitude
of doctors and nurses. Participants referred to the lack
of confidence by these professionals in pharmacists’
clinical abilities. This led to lack of acceptance of some
of their recommendations. Moreover pharmacists in
this study perceived that doctors and nurses accepted
more of their traditional roles and they appeared afraid
of pharmacists taking over their clinical roles.
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